as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹138.77
Change
+2.1 (1.54%)
Open
₹136.6
Prev. Close
₹136.67
Day High
₹139.0
Day Low
₹135.25
Volume Analysis
Traded
261,781
Delivered
132,213
Delivery %
50.51%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Low return on equity (2.84%)
- •Below-average fundamentals quality score (47/100)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹143.84 | ₹141.42 | ₹140.09 | ₹137.67 | ₹136.34 | ₹133.92 | ₹132.59 |
| Fibonacci | ₹141.42 | ₹139.99 | ₹139.1 | ₹137.67 | ₹136.24 | ₹135.35 | ₹133.92 |
| Camarilla | ₹139.8 | ₹139.46 | ₹139.11 | ₹137.67 | ₹138.43 | ₹138.08 | ₹137.74 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-9.14%
1 Week
-2.34%
1 Month
-10.02%
3 Months
-16.91%
6 Months
-17.44%
1 Year
-17.92%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹89.95
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
3.83%
Net margin 5.28% × asset turnover 0.6x × equity multiplier 1.21x
Company Overview
Sector
Chemicals
Market Cap
₹2,285 Cr
P/E (TTM)
28.0
ROE
2.84%
Book Value
₹108.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Nocil Limited scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 47/100. The strongest factor is Financial Strength (100/100), while Growth (8/100) is the weakest area to weigh before deciding. Notably: Low return on equity (2.84%); below-average fundamentals quality score (47/100). FII holding has been falling.
TopFund Score — Fundamentals Quality
47/100 — WeakData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 38.4%
- −The company has delivered a poor sales growth of 7.10% over past five years.
- −Promoter holding is low: 33.8%
- −Company has a low return on equity of 5.14% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Audio recording of 14 October 2026 analyst call uploaded on NOCIL’s website.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 351 | 341 | 356 | 372 | 363 | 318 | 340 | 336 | 321 | 316 | 330 | 403 | 427 |
| Expenses + | 306 | 292 | 312 | 331 | 325 | 294 | 305 | 306 | 298 | 289 | 309 | 358 | 391 |
| Operating Profit | 45 | 49 | 45 | 41 | 38 | 24 | 34 | 31 | 22 | 27 | 21 | 45 | 36 |
| OPM % | 13.0% | 14.0% | 13.0% | 11.0% | 10.0% | 8.0% | 10.0% | 9.0% | 7.0% | 8.0% | 6.0% | 11.0% | 8.0% |
| Other Income + | 5 | 6 | 25 | 9 | 8 | 9 | 6 | 7 | 10 | 1 | 14 | 6 | 7 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 14 | 14 | 14 | 14 | 14 |
| Profit before tax | 37 | 41 | 56 | 37 | 32 | 19 | 26 | 23 | 19 | 13 | 21 | 37 | 28 |
| Tax % | 26.0% | 26.0% | 25.0% | 26.0% | -30.0% | 32.0% | 20.0% | 25.0% | 35.0% | 31.0% | 19.0% | 25.0% | 15.0% |
| Net Profit + | 27 | 30 | 42 | 27 | 42 | 13 | 21 | 17 | 12 | 9 | 17 | 28 | 24 |
| EPS in Rs | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | -10 | 5 | -9 | -6 | 3 | -7 | -5 | -10 | -12 | -1 | -3 | 20 | 33 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 719 | 715 | 742 | 964 | 1,043 | 846 | 925 | 1,571 | 1,617 | 1,445 | 1,393 | 1,303 | 1,476 |
| Expenses + | 605 | 575 | 582 | 695 | 750 | 668 | 793 | 1,284 | 1,364 | 1,250 | 1,255 | 1,202 | 1,347 |
| Operating Profit | 114 | 140 | 160 | 269 | 293 | 178 | 132 | 288 | 253 | 195 | 137 | 101 | 129 |
| OPM % | 16.0% | 20.0% | 22.0% | 28.0% | 28.0% | 21.0% | 14.0% | 18.0% | 16.0% | 14.0% | 10.0% | 8.0% | 9.0% |
| Other Income + | 3 | 3 | 9 | 11 | 10 | 9 | 14 | 2 | 6 | 39 | 32 | 31 | 27 |
| Interest | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| Depreciation | 14 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 55 | 55 |
| Profit before tax | 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 76 | 100 |
| Tax % | 34.0% | 34.0% | 34.0% | 33.0% | 33.0% | 14.0% | 17.0% | 27.0% | 26.0% | 26.0% | 10.0% | 27.0% | — |
| Net Profit + | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 56 | 78 |
| EPS in Rs | 4 | 5 | 6 | 10 | 11 | 8 | 5 | 11 | 9 | 8 | 6 | 3 | 5 |
| Dividend Payout % | 28.0% | 25.0% | 30.0% | 24.0% | 22.0% | 32.0% | 38.0% | 28.0% | 34.0% | 38.0% | 32.0% | 45.0% | — |
| Sales growth | 21 | -1 | 4 | 30 | 8 | -19 | 9 | 70 | 3 | -11 | -4 | -6 | 12 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 254 | 309 | 750 | 882 | 998 | 1,020 | 1,119 | 1,279 | 1,385 | 1,532 | 1,595 | 1,606 | 1,639 |
| Borrowings + | 147 | 26 | 15 | 5 | 0 | 7 | 6 | 6 | 10 | 13 | 10 | 8 | 7 |
| Other Liabilities + | 193 | 186 | 233 | 279 | 279 | 250 | 324 | 380 | 295 | 304 | 284 | 329 | 376 |
| Total Liabilities | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,111 | 2,189 |
| Fixed Assets + | 311 | 307 | 543 | 528 | 657 | 797 | 918 | 909 | 888 | 870 | 855 | 831 | 814 |
| CWIP | 3 | 6 | 4 | 42 | 131 | 156 | 14 | 8 | 9 | 16 | 60 | 221 | 272 |
| Investments | 22 | 22 | 176 | 281 | 130 | 54 | 68 | 53 | 218 | 399 | 366 | 415 | 297 |
| Other Assets + | 418 | 347 | 438 | 480 | 524 | 434 | 614 | 859 | 742 | 730 | 776 | 645 | 807 |
| Total Assets | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,111 | 2,189 |
| Equity Capital | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 | 167 | 167 | 167 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 30 | 170 | 142 | 102 | 164 | 179 | 94 | -30 | 282 | 201 | 26 | 252 |
| Cash from Investing Activity + | -5 | -12 | -11 | -141 | -101 | -106 | -58 | 31 | -217 | -77 | -37 | -212 |
| Cash from Financing Activity + | -33 | -151 | -31 | -43 | -50 | -101 | 0 | -34 | -54 | -55 | -50 | -38 |
| Net Cash Flow | -8 | 8 | 101 | -82 | 13 | -28 | 35 | -33 | 11 | 68 | -62 | 2 |
| Free Cash Flow | 21 | 156 | 129 | 55 | -73 | 0 | 67 | -66 | 253 | 184 | -95 | 84 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 43 | 144 | 117 | 68 | 86 | 129 | 71 | 10 | 131 | 124 | 44 | 274 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 56.36% | 54.87% | 53.95% | 52.18% | 52.47% | 52.76% | 54.39% | 54.52% | 55.27% | 53.79% | 53.99% | 54.0% |
| Promoters | 33.84% | 33.84% | 33.84% | 33.78% | 33.78% | 33.76% | 33.76% | 33.76% | 33.76% | 33.76% | 33.76% | 33.76% |
| FII | 6.98% | 7.77% | 7.77% | 7.92% | 7.82% | 8.15% | 6.65% | 5.16% | 4.47% | 4.55% | 4.78% | 5.29% |
| DII | 2.83% | 3.51% | 4.44% | 6.13% | 5.93% | 5.33% | 5.2% | 6.57% | 6.5% | 7.92% | 7.48% | 6.96% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Nocil Limited (this stock) | 2,285 | 28.0 | 1.27 | 2.84% |
| J.g.chemicals Limited | 2,225 | 25.4 | 3.81 | 13.5% |
| Bhagiradha Chem & Inds L | 2,414 | 88.0 | 3.37 | 2.63% |
| Rossari Biotech Limited | 2,415 | 15.8 | 1.72 | 10.8% |
| Gsp Crop Science Limited | 1,980 | 22.0 | 2.39 | 16.5% |
| Bodal Chemicals Ltd | 1,902 | 13.2 | 1.5 | 1.97% |
| Jubilant Agri N Con Pro L | 2,677 | 24.9 | 5.07 | 33.2% |
Which Mutual Funds Hold Nocil Limited?
Frequently Asked Questions about Nocil Limited
Nocil Limited (NOCIL) closed at ₹138.77 on NSE on 19 November 2026, up 2.1 (1.54%) from the previous close.
Nocil Limited trades on the NSE (National Stock Exchange of India) under the symbol NOCIL.
Nocil Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 28.0.
Nocil Limited has a dividend yield of 1.1%.
Nocil Limited's 52-week high is ₹211.0 and its 52-week low is ₹125.0.
Nocil Limited has a market capitalisation of ₹2,285 crore.
Nocil Limited has a TopFund Quality Score of 47/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Nocil Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.